Codexis (CDXS) Cash & Equivalents (2010 - 2026)

Codexis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $36.6 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 99.63% year-over-year to $36.6 million in Q1 2026; TTM through Mar 2026 was $36.6 million, a 99.63% increase from a year earlier, with the FY2025 full-year figure at $50.8 million, up 163.67% from the prior year.
• Cash & Equivalents slipped to $36.6 million in Q1 2026 per CDXS's latest filing, from $50.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $114.0 million in Q4 2022 and bottomed at $1.6 million in Q3 2024.
• The 5-year median for Cash & Equivalents is $36.6 million (2026), against an average of $48.9 million.
• Biggest YoY gain for Cash & Equivalents was 5075.67% in 2022; the steepest drop was 98.51% in 2022.
• Year by year, Cash & Equivalents stood at $114.0 million in 2022, then slumped by 42.87% to $65.1 million in 2023, then sank by 70.42% to $19.3 million in 2024, then surged by 163.67% to $50.8 million in 2025, then declined by 28.0% to $36.6 million in 2026.
• Per Business Quant, the three latest CDXS Cash & Equivalents figures stand at $36.6 million (Q1 2026), $50.8 million (Q4 2025), and $25.4 million (Q3 2025).